Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Specific chromosomal aberrations in polycythemia vera

L Zech, C Gahrton, D Killander

    Blood
    |November 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Barriers and facilitators to recruitment, engagement, and retention of underrepresented populations in dementia prevention research: a scoping review.

    The journal of prevention of Alzheimer's disease·2026
    Same author

    Understanding Indirect Speech in Frontotemporal Dementia and Alzheimer's Disease Dementia: Validation of the Hinting Task - Dutch Version (HT-NL).

    Journal of the International Neuropsychological Society : JINS·2025
    Same author

    Differential linguistic features of verbal fluency in behavioral variant frontotemporal dementia and primary progressive aphasia.

    Applied neuropsychology. Adult·2022
    Same author

    The Naming Assessment in Multicultural Europe (NAME): Development and Validation in a Multicultural Memory Clinic.

    Journal of the International Neuropsychological Society : JINS·2022
    Same author

    Impaired Knowledge of Social Norms in Dementia and Psychiatric Disorders: Validation of the Social Norms Questionnaire-Dutch Version (SNQ-NL).

    Assessment·2021
    Same author

    Exploring Abstract Semantic Associations in the Frontotemporal Dementia Spectrum in a Dutch Population.

    Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists·2021
    Same journal

    Fibrocytes drive JAK2V617F-mutated myelofibrosis: pitavastatin reverses marrow fibrosis and anemia.

    Blood·2026
    Same journal

    Identifying steroid-refractory aGVHD before it happens.

    Blood·2026
    Same journal

    ELISA-negative HIT: antibody recognition and relevance.

    Blood·2026
    Same journal

    EBV and immunodeficiency: the odd couple drawn to the brain.

    Blood·2026
    Same journal

    A bone to pick with ferric carboxymaltose.

    Blood·2026
    Same journal

    A step toward streamlining HIT diagnosis.

    Blood·2026
    See all related articles

    Chromosomal abnormalities like chromosome 9 gain (+9) and chromosome 20 long arm deletion (20q-) are linked to polycythemia vera (PV). These changes appear disease-specific, not drug-induced, in bone marrow cells.

    Area of Science:

    • Hematology
    • Cytogenetics
    • Oncology

    Background:

    • Polycythemia vera (PV) is a myeloproliferative neoplasm characterized by increased red blood cell mass.
    • Chromosomal abnormalities are common in hematologic malignancies, but their specific role in PV pathogenesis and treatment response requires further elucidation.

    Purpose of the Study:

    • To investigate chromosomal aberrations in bone marrow cells of patients with polycythemia vera (PV).
    • To determine if observed chromosomal abnormalities are associated with the disease itself or with treatments like 32P, busulfan, or procarbazine.

    Main Methods:

    • Cytogenetic analysis using Q-, G-, and C-banding techniques on bone marrow cells from ten PV patients.
    • Patients were categorized based on treatment history: no cytotoxic drugs, 32P only, or 32P plus busulfan/procarbazine.

    Related Experiment Videos

    Main Results:

    • Identified specific chromosomal aberrations including an extra chromosome 9 (+9), an extra chromosome 8 (+8), and a deletion of the long arm of chromosome 20 (20q-).
    • The 20q- aberration was found in a patient treated only with venesection, and the +9 aberration was observed in a patient with no drug treatment.
    • Identical aberrations (20q- and +9) were found in both untreated and treated patient groups, suggesting a specific association with PV.

    Conclusions:

    • The chromosomal aberrations observed in PV patients, such as +9 and 20q-, are likely specifically associated with the disease rather than being induced by cytotoxic therapies.
    • These findings contribute to understanding the cytogenetic landscape of PV and may have implications for disease monitoring and prognosis.